Literature DB >> 12195558

Schnitzler's syndrome: what's new?

F Almerigogna, M G Giudizi, F Cappelli, S Romagnani.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12195558     DOI： 10.1046/j.1468-3083.2002.00458.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  3 in total

1.  TRAF family member-associated NF-κB activator (TANK) is a negative regulator of osteoclastogenesis and bone formation.

Authors:  Kenta Maruyama; Tatsukata Kawagoe; Takeshi Kondo; Shizuo Akira; Osamu Takeuchi
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

2.  Beneficial response to anakinra and thalidomide in Schnitzler's syndrome.

Authors:  H D de Koning; E J Bodar; A Simon; J C H van der Hilst; M G Netea; J W M van der Meer
Journal:  Ann Rheum Dis       Date:  2005-08-11       Impact factor: 19.103

Review 3.  [Differential diagnosis of urticaria].

Authors:  P Staubach
Journal:  Hautarzt       Date:  2007-04       Impact factor: 0.751
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.